Heren Health (300550.SZ): Termination of the planned change in control, company's stock will resume trading on June 2nd.

Hanren Technology (300550.SZ) announced that during the suspension period, the company's controlling shareholder Pan Yuan Investment and its concerted action person Pan Hong Investment, as well as the major shareholder Tongce Medical and the counterparty, have held extensive discussions on significant matters that may lead to a change in the company's controlling rights. However, due to the complexity of the matters involved, the parties did not reach a consensus on the core issues. After careful consideration and friendly negotiations, both parties have decided to terminate the planned major transaction. The company's stock will resume trading from June 2, 2026 (Tuesday).